Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03443921 | Divestment for Artery-involved Pancreatic Cancer | unknown | N/A | 122 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT03435770 | Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms | unknown | N/A | 10 | Singapore General HospitalOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT03435289 | A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer | unknown | Phase 1 | 24 | Atlantic Health SystemOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT03417843 | Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions.(yes) | unknown | N/A | 20 | HaEmek Medical Center, IsraelOTHER | 0 | Feb 13, 2018 | clinicaltrials |
| NCT03401827 | The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer | unknown | Phase 4 | 40 | Seoul National University HospitalOTHER | 1 | Feb 12, 2018 | clinicaltrials |
| NCT03214991 | Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer | unknown | — | 100 | Ji Kon RyuOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT02978547 | The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma(Metformin 001) | unknown | Phase 2 | 20 | British Columbia Cancer AgencyOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03345303 | Bortezomib in Intrahepatic Cholangiocellular Carcinoma | unknown | Phase 3 | 50 | Zhengang YuanOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT02862015 | Multicenter RCT of the Clinical Effectiveness of Oncothermia With Chemotherapy in Metastatic Pancreatic Cancer Patients(Oncothermia) | unknown | Phase 2 | 100 | Seoul National University HospitalOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT03098160 | Immunotherapy Study of Evofosfamide in Combination With Ipilimumab | unknown | Phase 1 | 69 | Threshold PharmaceuticalsINDUSTRY | 1 | Oct 30, 2017 | clinicaltrials |
| NCT03317886 | Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer | unknown | Phase 3 | 354 | Wakayama Medical UniversityOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT03316326 | S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer | unknown | Phase 2 | 35 | National Taiwan University HospitalOTHER | 0 | Oct 20, 2017 | clinicaltrials |
| NCT03127150 | Chyle Leak After Pancreatic Operation | unknown | — | 1,000 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT03129607 | A Study in Postoperative Pancreatic Fistula | unknown | — | 300 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT02801500 | Superior Bilioenteric Anastomosis by Magnetic Compressive Technique(CTREG) | unknown | N/A | 70 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Sep 21, 2017 | clinicaltrials |
| NCT02479984 | Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer | unknown | N/A | 193 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 14, 2017 | clinicaltrials |
| NCT01971281 | Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA) | unknown | Phase 1 / Phase 2 | 40 | NovoCure Ltd.INDUSTRY | 2 | Sep 13, 2017 | clinicaltrials |
| NCT03278015 | Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients | unknown | Phase 2 | 90 | Chinese PLA General HospitalOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT03269955 | The Effect of Application of TachoSil® in Pancreatoduodenectomy | unknown | Phase 4 | 126 | Asan Medical CenterOTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT03267173 | Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. | unknown | Early Phase 1 | 10 | First Affiliated Hospital of Harbin Medical UniversityOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT01563133 | Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas(CONTACT) | unknown | N/A | 330 | Mauna Kea TechnologiesINDUSTRY | 1 | Aug 29, 2017 | clinicaltrials |
| NCT03167112 | A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer(Folfirinox) | unknown | Phase 2 | 20 | Petr KavanOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT03251365 | Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer | unknown | Phase 2 / Phase 3 | 42 | Hospital General de Ciudad RealOTHER | 1 | Aug 16, 2017 | clinicaltrials |
| NCT03236883 | Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer(HST) | unknown | Phase 1 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 2, 2017 | clinicaltrials |
| NCT02823678 | Pancreas Volume and Diabetes Status Following Pancreatectomy | unknown | — | 100 | Florida Hospital Tampa Bay DivisionOTHER | 0 | Jul 28, 2017 | clinicaltrials |
| NCT03202199 | Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.(PACMI) | unknown | N/A | 125 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 26, 2017 | clinicaltrials |
| NCT01729481 | Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer(ML22774) | unknown | Phase 2 | 150 | Ludwig-Maximilians - University of MunichOTHER | 1 | Jul 19, 2017 | clinicaltrials |
| NCT03204019 | A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor | unknown | Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 29, 2017 | clinicaltrials |
| NCT03178812 | Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS) | unknown | N/A | 30 | Hillel Yaffe Medical CenterOTHER_GOV | 1 | Jun 7, 2017 | clinicaltrials |
| NCT03033186 | Everolimus TDM to Predict Long Term Toxicity(Foresight) | unknown | — | 40 | Maastricht University Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03166436 | RFA for Malignant Biliary Obstruction | unknown | N/A | 140 | Institute for Clinical and Experimental MedicineOTHER_GOV | 1 | May 30, 2017 | clinicaltrials |
| NCT01798147 | Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC). | unknown | Phase 2 | 24 | Johannes Gutenberg University MainzOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT03140007 | Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic .(Cholangioscopy) | unknown | N/A | 60 | Asian Institute of Gastroenterology, IndiaOTHER | 0 | May 8, 2017 | clinicaltrials |
| NCT02349724 | A Clinical Research of CAR T Cells Targeting CEA Positive Cancer | unknown | Phase 1 | 75 | Southwest Hospital, ChinaOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT02734680 | IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer(IFCSLAPC) | unknown | N/A | 70 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT02461836 | Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1) | unknown | Phase 2 | 513 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 5, 2017 | clinicaltrials |
| NCT03102268 | ncRNAs in Exosomes of Cholangiocarcinoma | unknown | — | 80 | The Second Hospital of Nanjing Medical UniversityOTHER | 1 | Apr 5, 2017 | clinicaltrials |
| NCT03063554 | EUS BD vs ERCP TP for Pancreatic Cancer(BILPAL) | unknown | N/A | 120 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT01438385 | Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders | unknown | — | 12,000 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT01439698 | Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry(RFA-Registry) | unknown | — | 200 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT01522573 | T-EUS for Gastrointestinal Disorders: A Multicenter Registry(EUSERCPReg) | unknown | — | 1,000 | Weill Medical College of Cornell UniversityOTHER | 2 | Feb 20, 2017 | clinicaltrials |
| NCT01755013 | Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma | unknown | Phase 2 / Phase 3 | 55 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT01771146 | Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer | unknown | N/A | 30 | Baylor Research InstituteOTHER | 1 | Jan 31, 2017 | clinicaltrials |
| NCT01964534 | Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer(AFUGEM) | unknown | Phase 2 | 114 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jan 31, 2017 | clinicaltrials |
| NCT01695447 | Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy | unknown | N/A | 100 | TingBo LiangOTHER | 1 | Jan 26, 2017 | clinicaltrials |
| NCT03013712 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer(CARTEPC) | unknown | Phase 1 / Phase 2 | 60 | First Affiliated Hospital of Chengdu Medical CollegeOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT03009253 | Translational Research on Locally Advanced Pancreatic Adenocarcinoma(TRLAPA) | unknown | N/A | 40 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 4, 2017 | clinicaltrials |
| NCT02124317 | Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer(NAPSPAC) | unknown | Phase 2 | 60 | Chinese PLA General HospitalOTHER | 1 | Dec 22, 2016 | clinicaltrials |
| NCT02839954 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02587689 | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Feb 23, 2018source: clinicaltrials